Healthcarefrom24/7 Wall St.2 weeks agoAbbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next?Abbott raised the quarterly dividend to $0.63, maintaining 13 years of growth while a 60.4% free cash flow payout ratio pressures sustainability.
Businessfrom24/7 Wall St.3 weeks ago5 Goldman Sachs Top Stock Picks Have Huge Upside Potential and Pay DividendsGoldman Sachs Conviction List highlights high-yield, high-upside stocks offering reliable dividends and strong investment conviction.
Businessfrom24/7 Wall St.1 month agoThe Dividend Aristocrats No One's Talking About (And Their 30+ Year Track Records)Lesser-known Dividend Aristocrats have raised dividends for decades, showing durable business models and resilient cash flow that enable ongoing dividend growth.
US newsfrom24/7 Wall St.7 months agoLive: Abbott Labs (NYSE: ABT) Q2 Earnings UpdatesAbbott Laboratories reports key financial figures including revenue of $11.06 billion and normalized EPS of $1.26, crucial for market performance.